AlphaCentric Life Sciences and Healthcare Fund Class A logo

AlphaCentric Life Sciences and Healthcare Fund Class A (LYFAX)

Market Closed
14 Aug, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
18. 58
+0.02
+0.1078%
$
- Market Cap
- Div Yield
0 Volume
$ 18.56
Previous Close
Add Transaction
Day Range
18.58 18.58
Year Range
12.49 19.32
Want to track LYFAX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

LYFAX closed Friday higher at $18.58, an increase of 0.1078% from Thursday's close, completing a monthly increase of 0.9234% or $0.17. Over the past 12 months, LYFAX stock gained 18.3439%.
LYFAX pays dividends to its shareholders, with the most recent payment made on Dec 31, 2024. The next estimated payment will be in 7 months ago on Dec 31, 2025 for a total of $0.018.
The stock of the company had never split.
The company's stock is traded on one exchange.

LYFAX Chart

AlphaCentric Life Sciences and Healthcare Fund Class A (LYFAX) FAQ

What is the stock price today?

The current price is $18.58.

On which exchange is it traded?

AlphaCentric Life Sciences and Healthcare Fund Class A is listed on NASDAQ (NMS).

What is its stock symbol?

The ticker symbol is LYFAX.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has AlphaCentric Life Sciences and Healthcare Fund Class A ever had a stock split?

No, there has never been a stock split.

AlphaCentric Life Sciences and Healthcare Fund Class A Profile

NASDAQ (NMS) Exchange
United States Country

Overview

This fund primarily focuses on the investment in securities of companies operating in the life sciences and healthcare sectors. These companies may be involved in the production or supply of facilities, supplies, technology, pharmaceuticals, equipment, devices, or services dedicated to the preservation and care of human or animal health. Under normal market conditions, the fund commits at least 80% of its net assets plus any borrowed funds for investment purposes towards these sectors. The management team defines these sectors broadly to include a wide range of activities and products related to healthcare and life sciences.

Products and Services

  • Facilities - This includes investments in companies that provide physical spaces and environments designed for healthcare purposes, such as hospitals, clinics, and specialized healthcare centers.
  • Supplies - Investments in suppliers of critical healthcare and life sciences materials, ranging from medical consumables to laboratory equipment essential for health preservation.
  • Technology - Focuses on companies that develop and supply healthcare technology, which can include medical software, telehealth services, and advanced medical devices that enhance patient care and outcomes.
  • Pharmaceuticals - The fund invests in pharmaceutical companies involved in the research, development, and distribution of medications for various health conditions, encompassing both traditional and innovative therapies.
  • Equipment and Devices - Targets investment in the production and supply of medical equipment and devices, ranging from diagnostic tools to surgical instruments and patient aids, essential for modern healthcare.
  • Services - Includes investments in companies providing healthcare services, from patient care and clinical services to wellness programs and healthcare management solutions.

Contact Information

Address: Willow Grove, PA19090
Phone: 866-447-4228